Skip to main content
    P

    Palisade Bio Inc (PALI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.01
    -0.02 (-1.94%)

    Market Cap: $201.01M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Palisade Bio Inc (PALI) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Palisade Bio (PALI) has a latest price of $1.01 on Nov 17, 2026, 64.7% below its 52-week high of $2.86. Its price fell 52.8% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 71.3%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $520,735.43 in Jun 2017 and its lowest $0.68 in Aug 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart PALI with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PALI.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 53.2%, and over 6 months it fell 44.2%. The month-end price fell 86.1% over the 3 years through Oct 2026, a compound annual decline of 48.1%.

    PeriodChange
    1 month-24.6%
    3 months-53.2%
    6 months-44.2%
    12 months-52.8%
    12 months, with dividends-52.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-86.1%-48.1%
    5 years-99.9%-77.6%
    10 years-100.0%-71.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 42.4%, and its weakest was 2022, when it fell 92.0%.

    YearCloseChange
    2026 through Oct 2026$1.16-50.6%
    2025$2.35+42.4%
    2024$1.65-81.3%
    2023$8.85-88.7%
    2022$77.96-92.0%
    2021$974.51-75.4%
    2020$3,957.23-11.1%
    2019$4,451.88-84.2%
    2018$28,159.29-81.8%
    2017$154,691.70-51.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 29.6% below its 50-day average of $1.43 and 44.4% below its 200-day average of $1.82.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.01
    52-week high$2.86-64.7%
    52-week low$1.010.0%
    50-day average$1.43-29.6%
    200-day average$1.82-44.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 96.3%.

    MeasureValue
    1-year beta1.25
    Largest fall, 1 year-63.9%
    Largest fall, 3 years-96.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About PALI

    What is PALI's 1-year price change?

    Palisade Bio's price fell 52.8% over the past 12 months. With dividends included, the 12-month total return was -52.8%.

    What is PALI's 5-year price change?

    Palisade Bio's month-end price fell 99.9% over the 5 years through Oct 2026, a compound annual decline of 77.6%. These figures leave out dividends.

    What is PALI's 52-week high and low?

    Palisade Bio's 52-week high is $2.86 and its 52-week low is $1.01. Its latest price of $1.01 on Nov 17, 2026 is 64.7% below the high.

    What is PALI's beta?

    Palisade Bio's 1-year beta against the S&P 500 is 1.25, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 63.9%.

    Is the PALI chart free?

    Yes. Advanced Charting for PALI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.